CARM — Carisma Therapeutics Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1485003 ·
Last close
$0.00
Market Cap
$4.2K
52W High
$0.05
52W Low
$0.00
ADV30
33,148
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 45,250,000 | — | 43,814,000 | 44,717,000 | 6,554,000 | 2,777,000 | 7,421,000 |
| Jun 2025 | 0 | — | -5,778,000 | -9,774,000 | 5,012,000 | 1,999,000 | 51,017,000 |
| Mar 2025 | 3,729,000 | — | -9,334,000 | -9,266,000 | 15,953,000 | 7,740,000 | 52,615,000 |
| Dec 2024 | 3,653,000 | — | -17,855,000 | -17,635,000 | 30,458,000 | 17,909,000 | 58,367,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-22,415,000
Investing CF
$687,000
Financing CF
$-2,376,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.31
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-279,902,000
Inventory
—
Receivables
$1,636,000
ST Investments
—
EBIT TTM
$10,847,000
Pretax Income TTM
$8,042,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$52,632,000
EBITDA
$14,177,000
Free Cash Flow
$13,047,375
Enterprise Value
$-2,010,815
Total Cash
$2,777,000
Total Debt
$762,000
Shares Out
41,845,078
Trailing EPS
$0.19
Book Value
$-0.02
ROE
—
ROA
33.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 19,632,000 | -62,179,000 | -60,477,000 | 30,458,000 | 58,367,000 | — | -59,917,000 |
| Dec 2023 | 14,919,000 | -88,731,000 | -86,879,000 | 89,554,000 | 63,022,000 | — | -81,177,000 |
| Dec 2022 | 9,834,000 | -56,162,000 | -61,226,000 | 72,153,000 | 214,823,000 | — | -5,116,000 |
| Dec 2021 | 0 | -40,794,000 | -40,784,000 | 35,449,000 | 9,425,000 | — | -37,328,000 |
TTM Snapshot
Revenues TTM
$17,641,000
NetIncome TTM
$9,336,000
OpCashFlow TTM
$0
Assets (Latest)
$89,554,000
Forward EPS
$-0.91
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| OCEA | Ocean Biomedical, Inc. | $46.5K | $0.00 | — |
| ADTX | Aditxt, Inc. | $129.8K | $0.25 | — |
| BDPT | BIOADAPTIVES, INC. | $132.1K | $0.01 | — |
| GCAN | Greater Cannabis Company, Inc. | $137.0K | $0.14 | — |
| RGBP | Regen BioPharma Inc | $153.6K | $0.00 | — |
News headlines (Yahoo Finance, 1h cache)
CARMILA: Information Concerning the Total Number of Voting Rights and Share
2026-04-02 15:40 · Yahoo
Carmila Makes its 2025 Universal Registration Document Available
2026-04-01 14:02 · Yahoo
Liberate Bio gains licences for myeloid-specific CAR design patents
2026-03-06 11:11 · Yahoo
Liberate Bio Secures Myeloid-Optimized CAR Design Licenses to Advance In Vivo CAR-M Programs
2026-03-05 12:15 · Yahoo
Carisma Announces Delisting from Nasdaq and SEC Deregistration
2025-12-05 16:16 · Yahoo
BC-Most Active Stocks
2025-09-02 14:30 · Yahoo
Carisma Therapeutics, OrthoCellix enter definitive merger agreement
2025-06-24 17:07 · Yahoo
Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases
2025-06-23 11:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.